Technical Analysis for AEMD - Aethlon Medical, Inc.

Grade Last Price % Change Price Change
grade F 0.4241 0.00% 0.00
AEMD closed down 1.37 percent on Friday, May 17, 2019, on 78 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Down
See historical AEMD trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -1.37%
Calm After Storm Range Contraction -1.37%
Lower Bollinger Band Walk Weakness -1.37%

Older signals for AEMD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aethlon Medical, Inc., a medical device company, focuses on creating devices for the treatment of cancer, infectious diseases, and other life-threatening conditions. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The company's Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. It is also developing exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. The company was founded in 1991 and is based in San Diego, California.
Medicine Health Cancer Biology Infectious Diseases Treatment Of Cancer Neurological Disorders Infectious Causes Of Cancer Hepatitis Antiviral Drug Healthcare Associated Infections Virus Sepsis Exosome Vesicles
Is AEMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.74
52 Week Low 0.4
Average Volume 159,269
200-Day Moving Average 1.0947
50-Day Moving Average 0.8092
20-Day Moving Average 0.654
10-Day Moving Average 0.5575
Average True Range 0.0863
ADX 50.0
+DI 11.1792
-DI 28.002
Chandelier Exit (Long, 3 ATRs ) 0.5911
Chandelier Exit (Short, 3 ATRs ) 0.6589
Upper Bollinger Band 0.9164
Lower Bollinger Band 0.3916
Percent B (%b) 0.06
BandWidth 80.244648
MACD Line -0.1051
MACD Signal Line -0.083
MACD Histogram -0.0221
Fundamentals Value
Market Cap 3.77 Million
Num Shares 8.9 Million
EPS -0.87
Price-to-Earnings (P/E) Ratio -0.49
Price-to-Sales 22.89
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.49
Resistance 3 (R3) 0.49 0.47 0.48
Resistance 2 (R2) 0.47 0.45 0.47 0.48
Resistance 1 (R1) 0.45 0.44 0.44 0.45 0.47
Pivot Point 0.42 0.42 0.42 0.42 0.42
Support 1 (S1) 0.40 0.41 0.39 0.40 0.37
Support 2 (S2) 0.38 0.39 0.38 0.37
Support 3 (S3) 0.35 0.38 0.37
Support 4 (S4) 0.35